The 20 Best Familial Prostate Cancer Doctors Near Me in Forest Hills, NY

Howard Scher is an Oncologist practicing medicine in New York, New York. Dr. Scher is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Orchiectomy, and Prostatectomy. Dr. Scher is currently accepting new patients.

Michael Morris is an Oncologist practicing medicine in New York, New York. Dr. Morris is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Vocal Cord Dysfunction, Hip Replacement, and Knee Replacement. Dr. Morris is currently accepting new patients.

Dana Rathkopf is an Oncologist practicing medicine in New York, New York. Dr. Rathkopf is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy. Dr. Rathkopf is currently accepting new patients.

Behfar Ehdaie is a Urologist practicing medicine in New York, New York. Dr. Ehdaie is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Ehdaie is currently accepting new patients.

Ashutosh Tewari is a Urologist practicing medicine in New York, New York. Dr. Tewari is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Vasectomy. Dr. Tewari is currently accepting new patients.

An internationally renowned expert in prostate cancer treatment and radiation oncology pioneer, Louis Potters, MD, FASTRO, FABS, FACR serves as Senior Vice President and Deputy Physician-in-Chief of the Northwell Cancer Institute while chairing its Department of Radiation Medicine. His contributions span clinical excellence, research innovation, and healthcare policy development. As a key architect of national cancer treatment guidelines and advisor to the US Nuclear Regulatory Commission, Dr. Potters has helped shape modern radiation oncology standards and safety protocols.His distinguished service includes positions on the Commission on Cancer executive committee, National Quality Forum panels, and multiple Health and Human Services committees, where he has been instrumental in advancing healthcare quality nationwide. As senior editor of Practical Radiation Oncology and editorial board member for leading journals including Oncology and Brachytherapy, he continues to guide professional discourse and scientific advancement in the field. A member of the prestigious Alpha Omega Alpha honor society, Dr. Potters has demonstrated exceptional commitment to medical excellence throughout his career. He recognized year over year in a number of Best Doctor awards by Castle Connolly, is featured in New York Magazine and as a NY Times SuperDoc.Throughout his 32-year clinical practice treating thousands of prostate cancer patients, Dr. Potters has pioneered innovative approaches to patient care and quality assurance. His leadership of one of the nation's largest radiation oncology departments has fostered excellence in patient care, groundbreaking research, and comprehensive medical education. The Smarter Radiation Oncology program he developed has gained international recognition for setting new standards in quality metrics, safety protocols, and patient experience. His academic contributions include over 200 peer-reviewed publications that have significantly advanced the field of radiation oncology and prostate cancer treatment.Under his guidance, the Northwell Health Department of Radiation Medicine has become a leading force in implementing cutting-edge treatments while training the next generation of oncology leaders. Dr. Potters continues to drive innovation in personalized cancer care, process improvement, and clinical outcomes, maintaining Northwell's position at the forefront of modern oncology practice. Dr. Potters is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Potters is board certified in American Board Of Internal Medicine and American Board Of Radiology/Radiation Oncology.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

Sang Sim is an Internal Medicine specialist and a Radiation Oncologist practicing medicine in New Hyde Park, New York. Dr. Sim is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy. Dr. Schwartz is board certified in American Board Of Urology.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

William Bodner is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Bodner is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Familial Prostate Cancer.

Roberto Lipsztein is a Radiation Oncologist practicing medicine in Forest Hills, New York. Dr. Lipsztein is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Endometrial Stromal Sarcoma.

Bhupesh Parashar is a Radiation Oncologist practicing medicine in Forest Hills, New York. Dr. Parashar is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adult Soft Tissue Sarcoma, Lung Cancer, Pleuropulmonary Blastoma, and Gastrostomy. Dr. Parashar is board certified in American Board Of Radiology/Radiation Oncology.

Christopher Hartman is a Urologist practicing medicine in Rego Park, New York. Dr. Hartman is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Enlarged Prostate (BPH), Kidney Stones, Lithotripsy, and Ureteroscopy. Dr. Hartman is board certified in American Board Of Urology.

Jane Cho is an Oncologist and a Urologist practicing medicine in Rego Park, New York. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Obstructive Uropathy, Bladder Cancer, Urinary Tract Infection (UTI), Cystectomy, and Ureteroscopy. Dr. Cho is board certified in American Board Of Urology.

Gabriel Jung is a Hematologist and an Oncologist practicing medicine in Rego Park, New York. Dr. Jung is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Thrombocytopenia, Anemia, Pancreatectomy, and Endoscopy. Dr. Jung is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Gerald Wang is a Urologist practicing medicine in Fresh Meadows, New York. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Wang is currently accepting new patients.